Market Cap 2.21B
Revenue (ttm) 51.95M
Net Income (ttm) -265.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -511.92%
Debt to Equity Ratio 0.12
Volume 2,764,700
Avg Vol 2,931,226
Day's Range N/A - N/A
Shares Out 218.96M
Stochastic %K 63%
Beta 0.89
Analysts Strong Sell
Price Target $27.10

Company Profile

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that i...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 357 4000
Address:
15 Crosby Drive, Bedford, United States
MaxKlim
MaxKlim Jun. 24 at 8:39 PM
$OCUL https://x.com/zipjet/status/2069869138730742260?s=46
0 · Reply
rizzato
rizzato Jun. 24 at 7:49 PM
$OCUL let's leave me to understand Tmoney. you are saying that both company ocul and eypt will not have a green future and they are kidding us, means that big investors that own around the 90% of the shares and the great management of both company doesn't understand anything can I tell you that that sound really strange? is not easier to say again I'm totally short and trying to push the share price down to make money who are you the genius inside the lamp?????????
2 · Reply
nicky7
nicky7 Jun. 24 at 7:30 PM
$OCUL 40 incoming
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 7:28 PM
$OCUL big time ouch. still time to short before Ollin takes over.
0 · Reply
moneybagged
moneybagged Jun. 24 at 6:40 PM
$OCUL Did not expect such shorting!!! I have my orders in👌😎
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:37 PM
$OCUL nice group of bulls you got here- moronic and transphobic. guy is obsessed with calling people trans. pretty telling if you ask me.
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:05 PM
$OCUL thanks for the laugh. yeah, $35 incoming when it couldn't crack (checks notes) $10.50. might wanna call pravin and ask him how those FDA talks are going now that Ollin is clearly superior and is ACTUALLY a game changing drug. tough pill for yall to swallow, market gets it though! little nicky should go back to eating popeyes and saving new york from the devil, because he's clearly losing it. LOL
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:03 PM
$OCUL hey siri, post the 6M chart for JJ to see. anyone can manipulate a chart to make a point, you dont even need a jaguar to do so!
2 · Reply
nicky7
nicky7 Jun. 24 at 4:43 PM
$OCUL 35 incoming
0 · Reply
SmokenTuna
SmokenTuna Jun. 24 at 3:42 PM
$OCUL 1000 more for me! Let’s rock!
0 · Reply
Latest News on OCUL
Ocular Therapeutix Transcript: Investor Day 2026

Jun 17, 2026, 2:00 PM EDT - 7 days ago

Ocular Therapeutix Transcript: Investor Day 2026


Ocular Therapeutix Press release: FY 2026

Jun 17, 2026, 2:00 PM EDT - 7 days ago

Ocular Therapeutix Press release: FY 2026


Ocular Therapeutix Slides: FY 2026

Jun 17, 2026, 2:00 PM EDT - 7 days ago

Ocular Therapeutix Slides: FY 2026


Ocular Therapeutix trading resumes

2026-06-17T13:15:09.000Z - 7 days ago

Ocular Therapeutix trading resumes


Ocular Therapeutix to resume trading at 9:15 am ET

2026-06-17T12:56:01.000Z - 7 days ago

Ocular Therapeutix to resume trading at 9:15 am ET


Ocular Therapeutix trading halted, news pending

2026-06-17T12:40:11.000Z - 7 days ago

Ocular Therapeutix trading halted, news pending


Ocular Therapeutix Transcript: AGM 2026

Jun 10, 2026, 8:30 AM EDT - 14 days ago

Ocular Therapeutix Transcript: AGM 2026


Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Jun 2, 2026, 7:00 AM EDT - 22 days ago

Ocular Therapeutix™ to Host Investor Day on June 17, 2026


Ocular Therapeutix Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 7 weeks ago

Ocular Therapeutix Earnings Call Transcript: Q1 2026


Ocular Therapeutix Earnings release: Q1 2026

May 5, 2026, 8:00 AM EDT - 7 weeks ago

Ocular Therapeutix Earnings release: Q1 2026


Ocular Therapeutix Quarterly report: Q1 2026

May 5, 2026, 8:00 AM EDT - 7 weeks ago

Ocular Therapeutix Quarterly report: Q1 2026


Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)

2026-05-05T11:59:32.000Z - 7 weeks ago

Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)


Ocular Therapeutix Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

Ocular Therapeutix Proxy statement: Proxy filing


Ocular Therapeutix Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 7 weeks ago

Ocular Therapeutix Proxy statement: Proxy filing


Ocular Therapeutix enrolls first patient in Axpali trial

2026-04-29T13:00:19.000Z - 2 months ago

Ocular Therapeutix enrolls first patient in Axpali trial


Ocular Therapeutix Transcript: HCW @ Home

Apr 27, 2026, 2:30 PM EDT - 2 months ago

Ocular Therapeutix Transcript: HCW @ Home


Ocular Therapeutix reports additional Axpaxli trial data

2026-04-13T11:22:45.000Z - 2 months ago

Ocular Therapeutix reports additional Axpaxli trial data


Ocular Therapeutix price target raised to $27 from $24 at BofA

2026-03-03T11:45:13.000Z - 4 months ago

Ocular Therapeutix price target raised to $27 from $24 at BofA


Ocular Therapeutix Transcript: Study update

Mar 2, 2026, 7:30 AM EST - 4 months ago

Ocular Therapeutix Transcript: Study update


Ocular Therapeutix Transcript: Study result

Feb 17, 2026, 8:00 AM EST - 4 months ago

Ocular Therapeutix Transcript: Study result


Ocular Therapeutix Press release: Study result

Feb 17, 2026, 8:00 AM EST - 4 months ago

Ocular Therapeutix Press release: Study result


Ocular Therapeutix reports Q4 EPS (29c), consensus (34c)

2026-02-05T12:05:13.000Z - 4 months ago

Ocular Therapeutix reports Q4 EPS (29c), consensus (34c)


Ocular Therapeutix Annual report: Q4 2025

Feb 5, 2026, 7:00 AM EST - 4 months ago

Ocular Therapeutix Annual report: Q4 2025


Ocular Therapeutix Earnings release: Q4 2025

Feb 5, 2026, 7:00 AM EST - 4 months ago

Ocular Therapeutix Earnings release: Q4 2025


Ocular Therapeutix rises 11.7%

2026-01-15T15:06:31.000Z - 5 months ago

Ocular Therapeutix rises 11.7%


Ocular Therapeutix Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Ocular Therapeutix Earnings Call Transcript: Q3 2025


Ocular Therapeutix Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Ocular Therapeutix Quarterly report: Q3 2025


Ocular Therapeutix Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Ocular Therapeutix Earnings release: Q3 2025


Ocular Therapeutix Transcript: Investor Day 2025

Sep 30, 2025, 2:00 PM EDT - 9 months ago

Ocular Therapeutix Transcript: Investor Day 2025


Ocular Therapeutix Press release: FY 2025

Sep 30, 2025, 2:00 PM EDT - 9 months ago

Ocular Therapeutix Press release: FY 2025


Ocular Therapeutix Slides: FY 2025

Sep 30, 2025, 2:00 PM EDT - 9 months ago

Ocular Therapeutix Slides: FY 2025


Ocular Therapeutix Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Ocular Therapeutix Earnings Call Transcript: Q2 2025


Ocular Therapeutix Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Ocular Therapeutix Quarterly report: Q2 2025


Ocular Therapeutix Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

Ocular Therapeutix Earnings release: Q2 2025


Ocular Therapeutix Quarterly report: Q1 2025

May 5, 2025, 7:00 AM EDT - 1 year ago

Ocular Therapeutix Quarterly report: Q1 2025


Ocular Therapeutix Earnings release: Q1 2025

May 5, 2025, 7:00 AM EDT - 1 year ago

Ocular Therapeutix Earnings release: Q1 2025


Ocular Therapeutix Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ocular Therapeutix Proxy statement: Proxy Filing


Ocular Therapeutix Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Ocular Therapeutix Proxy statement: Proxy Filing


Ocular Therapeutix Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Ocular Therapeutix Proxy statement: Proxy Filing


Ocular Therapeutix Slides: Corporate Presentation

Mar 27, 2025, 7:00 PM EDT - 1 year ago

Ocular Therapeutix Slides: Corporate Presentation


Ocular Therapeutix Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

Ocular Therapeutix Earnings Call Transcript: Q4 2024


Ocular Therapeutix Annual report: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

Ocular Therapeutix Annual report: Q4 2024


Ocular Therapeutix Earnings release: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

Ocular Therapeutix Earnings release: Q4 2024


Ocular Therapeutix Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Ocular Therapeutix Earnings Call Transcript: Q3 2024


Ocular Therapeutix Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Ocular Therapeutix Quarterly report: Q3 2024


Ocular Therapeutix Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Ocular Therapeutix Earnings release: Q3 2024


Ocular Therapeutix Transcript: UBS Virtual Ophthalmology Day

Oct 2, 2024, 3:00 PM EDT - 1 year ago

Ocular Therapeutix Transcript: UBS Virtual Ophthalmology Day


Ocular Therapeutix Earnings Call Transcript: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Earnings Call Transcript: Q2 2024


Ocular Therapeutix Quarterly report: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Quarterly report: Q2 2024


Ocular Therapeutix Earnings release: Q2 2024

Aug 7, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Earnings release: Q2 2024


Ocular Therapeutix™ Reports Second Quarter 2024 Results

Aug 7, 2024, 7:10 AM EDT - 2 years ago

Ocular Therapeutix™ Reports Second Quarter 2024 Results


Ocular Therapeutix Transcript: Investor Day 2024

Jun 13, 2024, 2:00 PM EDT - 2 years ago

Ocular Therapeutix Transcript: Investor Day 2024


Ocular Therapeutix Slides: FY 2024

Jun 13, 2024, 2:00 PM EDT - 2 years ago

Ocular Therapeutix Slides: FY 2024


Ocular Therapeutix® to Host Investor Day on June 13, 2024

Jun 5, 2024, 7:30 AM EDT - 2 years ago

Ocular Therapeutix® to Host Investor Day on June 13, 2024


Ocular Therapeutix™ Reports First Quarter 2024 Results

May 7, 2024, 4:05 PM EDT - 2 years ago

Ocular Therapeutix™ Reports First Quarter 2024 Results


Ocular Therapeutix Quarterly report: Q1 2024

May 7, 2024, 4:00 PM EDT - 2 years ago

Ocular Therapeutix Quarterly report: Q1 2024


Ocular Therapeutix Earnings release: Q1 2024

May 7, 2024, 4:00 PM EDT - 2 years ago

Ocular Therapeutix Earnings release: Q1 2024


Ocular Therapeutix Proxy statement: Proxy Filing

May 7, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Proxy statement: Proxy Filing


Ocular Therapeutix Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Proxy statement: Proxy Filing


Ocular Therapeutix Proxy statement: Proxy Filing

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Ocular Therapeutix Proxy statement: Proxy Filing


MaxKlim
MaxKlim Jun. 24 at 8:39 PM
$OCUL https://x.com/zipjet/status/2069869138730742260?s=46
0 · Reply
rizzato
rizzato Jun. 24 at 7:49 PM
$OCUL let's leave me to understand Tmoney. you are saying that both company ocul and eypt will not have a green future and they are kidding us, means that big investors that own around the 90% of the shares and the great management of both company doesn't understand anything can I tell you that that sound really strange? is not easier to say again I'm totally short and trying to push the share price down to make money who are you the genius inside the lamp?????????
2 · Reply
nicky7
nicky7 Jun. 24 at 7:30 PM
$OCUL 40 incoming
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 7:28 PM
$OCUL big time ouch. still time to short before Ollin takes over.
0 · Reply
moneybagged
moneybagged Jun. 24 at 6:40 PM
$OCUL Did not expect such shorting!!! I have my orders in👌😎
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:37 PM
$OCUL nice group of bulls you got here- moronic and transphobic. guy is obsessed with calling people trans. pretty telling if you ask me.
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:05 PM
$OCUL thanks for the laugh. yeah, $35 incoming when it couldn't crack (checks notes) $10.50. might wanna call pravin and ask him how those FDA talks are going now that Ollin is clearly superior and is ACTUALLY a game changing drug. tough pill for yall to swallow, market gets it though! little nicky should go back to eating popeyes and saving new york from the devil, because he's clearly losing it. LOL
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 5:03 PM
$OCUL hey siri, post the 6M chart for JJ to see. anyone can manipulate a chart to make a point, you dont even need a jaguar to do so!
2 · Reply
nicky7
nicky7 Jun. 24 at 4:43 PM
$OCUL 35 incoming
0 · Reply
SmokenTuna
SmokenTuna Jun. 24 at 3:42 PM
$OCUL 1000 more for me! Let’s rock!
0 · Reply
Twitgb
Twitgb Jun. 24 at 3:17 PM
$OCUL when things dont go well and ghouls start to crawl out, you can be sure it will turn for the better. Always pestering when the tides turn. You will see, hppened on other boards. Lets go up 30% and they will find another board to piss.
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 3:13 PM
$OCUL y'all had your chance to get out in the mid 10's. you would've looked dare i say, smart? shorts own this one- and if you're looking to $EYPT to save you, that's equally as pathetic.
0 · Reply
TickrTalk0007
TickrTalk0007 Jun. 24 at 3:08 PM
$OCUL pharma has way too many options to buy from... Axpaxli is not the one.
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 2:52 PM
$OCUL little buddy and his sidekick are so upset today. maybe they should invest in Wendy's LMAO
1 · Reply
Twitgb
Twitgb Jun. 24 at 2:37 PM
$VKTX $OCUL Here is the fortuneteller, with his imaginary friends. He is always right, right? :D
1 · Reply
KimboIce
KimboIce Jun. 24 at 2:24 PM
$OCUL $EYPT you are at break even . Quit while you can . There are far less risky shorts out there . If EYPT Lugano results are positive, I can see Ocul go up 30-50% on the news. MM’s are long-term strategic thinkers . They are not nubes tracking the daily . The market sees two companies = 2X resources fasts tracks new SOC . It’s ironic that management teams hate each other and need each other at the same time .
1 · Reply
rizzato
rizzato Jun. 24 at 2:15 PM
$OCUL Wellcome back DROPPPPPPPPPPPPPPPPPPPP
0 · Reply
TickrTalk0007
TickrTalk0007 Jun. 24 at 2:05 PM
$OCUL great defense by bulls... this is going to sting
1 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 2:03 PM
$OCUL LMAO- $XBI hits $150 and this is going back to the $9's. such easy money, glad i'm not a sheep/moron
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 1:54 PM
$OCUL yeah big pharma simply doesn't care. no one wants to be caught buying Iveric #2. sell for $11, it's still a rip off for whoever acquires it. no one, and i mean no one, is interested in buying this.
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 1:52 PM
$OCUL another successful bagholder! congrats!
0 · Reply
Tmoney85285
Tmoney85285 Jun. 24 at 1:51 PM
$OCUL bad news for the cult this morning. yikes.
0 · Reply